Drug and Medication Analysis & Statistics, February 2015 (p4)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

91-120 of about 4 600 reports

Purchase Reports From Reputable Market Research Publishers

Bacterial Conjunctivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Bacterial Conjunctivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Bacterial Conjunctivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Drug and Medication
  • Countries : United States
Bacterial Endocarditis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Bacterial Endocarditis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Bacterial Endocarditis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Drug and Medication
  • Countries : United States
Berylliosis (Chronic Beryllium Disease)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Berylliosis (Chronic Beryllium Disease)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Berylliosis (Chronic Beryllium Disease)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs ...

  • Industries : Drug and Medication
  • Countries : United States
Bronchitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Bronchitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Bronchitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

  • Industries : Drug and Medication
  • Countries : United States
Bronchospasm-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Bronchospasm-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Bronchospasm-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

  • Industries : Drug and Medication
  • Countries : United States
Burns-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Burns-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Burns-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Burns. ...

  • Industries : Drug and Medication
  • Countries : United States
Candidiasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Candidiasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Candidiasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

  • Industries : Drug and Medication
  • Countries : United States
Cellulitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Cellulitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Cellulitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

  • Industries : Drug and Medication
  • Countries : United States
Chancroid-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Chancroid-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Chancroid-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the ...

  • Industries : Drug and Medication
  • Countries : United States
Community Acquired Pneumonia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Community Acquired Pneumonia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Community Acquired Pneumonia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Drug and Medication
  • Countries : United States
Constipation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Constipation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Constipation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

  • Industries : Drug and Medication
  • Countries : United States
Endocarditis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Endocarditis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Endocarditis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

  • Industries : Drug and Medication
  • Countries : United States
Epilepsy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Epilepsy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Epilepsy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the ...

  • Industries : Drug and Medication
  • Countries : United States
Erectile Dysfunction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Erectile Dysfunction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Erectile Dysfunction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Drug and Medication
  • Countries : United States
Escherichia Coli Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Escherichia Coli Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Escherichia Coli Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Drug and Medication
  • Countries : United States
Esophagitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Esophagitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Esophagitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

  • Industries : Drug and Medication
  • Countries : United States
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase ...

  • Industries : Drug and Medication
  • Countries : United States
Fungal Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Fungal Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Fungal Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Drug and Medication
  • Countries : United States
Genital Herpes-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Genital Herpes-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Genital Herpes-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

  • Industries : Drug and Medication
  • Countries : United States
Glaucoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Glaucoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Glaucoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the ...

  • Industries : Drug and Medication
  • Countries : United States
Gonorrhea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Gonorrhea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Gonorrhea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the ...

  • Industries : Drug and Medication
  • Countries : United States
HIV / AIDS-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

HIV / AIDS-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “HIV / AIDS-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

  • Industries : Drug and Medication
  • Countries : United States
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive ...

  • Industries : Drug and Medication
  • Countries : United States
Hypercalcemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Hypercalcemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Hypercalcemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

  • Industries : Drug and Medication
  • Countries : United States
Hypercholesterolemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Hypercholesterolemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Hypercholesterolemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Drug and Medication
  • Countries : United States
Hyperlipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Hyperlipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Hyperlipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

  • Industries : Drug and Medication
  • Countries : United States
Insomnia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Insomnia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Insomnia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the ...

  • Industries : Drug and Medication
  • Countries : United States
Keratitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Keratitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Keratitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the ...

  • Industries : Drug and Medication
  • Countries : United States
Keratoconjunctivitis sicca (Dry Eye)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Keratoconjunctivitis sicca (Dry Eye)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Keratoconjunctivitis sicca (Dry Eye)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs ...

  • Industries : Drug and Medication
  • Countries : United States
Lichen Simplex Chronicus (Neurodermatitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Lichen Simplex Chronicus (Neurodermatitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Lichen Simplex Chronicus (Neurodermatitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline ...

  • Industries : Drug and Medication
  • Countries : United States
About 12 000 reports

Download Unlimited Documents from Trusted Public Sources

Cancer Drug Market in Australia

  • February 2015
    2 pages
  • Cancer Drug  

  • Australia  

    Oceania  

View report >

Opioid Industry

February 2015

Vaccine Industry

February 2015

62 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

GlaxoSmithKline PLC

United Kingdom

Novartis Inc.

Switzerland

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.